These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 4337465)

  • 1. [The influence of intraventricularly administered angiotensin II, bradykinin and eledoisin on arterial blood pressure, respiration and electrocardiogram].
    Cuparencu B; Ticşa I; Safta L; Csutak V; Mocan R
    Acta Biol Med Ger; 1971; 27(2):435-41. PubMed ID: 4337465
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of the intraventricular administration of angiotensin II, bradykinin and eledoisin on the arterial blood pressure, respiratory movements and electrocardiogram.
    Cuparencu B; Ticşa I; Safta L; Csutak V; Mocan R
    Rev Roum Physiol; 1969; 6(3):213-20. PubMed ID: 4323315
    [No Abstract]   [Full Text] [Related]  

  • 3. Centrally mediated cardiovascular and EEG responses to bradykinin and eledoisin.
    Pearson L; Lambert GA; Lang WJ
    Eur J Pharmacol; 1969 Nov; 8(2):153-8. PubMed ID: 4391502
    [No Abstract]   [Full Text] [Related]  

  • 4. Apnea, bradycardia, hypotension and muscular contraction induced by intracarotid injection of bradykinin.
    Riccioppo Neto F; Corrado AP; Rocha e Silva M
    J Pharmacol Exp Ther; 1974 Aug; 190(2):316-26. PubMed ID: 4449043
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of imipramine on adrenergic responses.
    Shaikh AA; Gulati OD; Parikh HM
    Indian J Physiol Pharmacol; 1973; 17(4):299-309. PubMed ID: 4369955
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence that the area postrema mediates the central cardiovascular response to angiotensin II.
    Joy MD; Lowe RD
    Nature; 1970 Dec; 228(5278):1303-4. PubMed ID: 4321187
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reflex cardiocirculatory and respiratory responses caused by bradykinin injections into the femoral and carotid circulatory areas].
    Tallarida G; Baldoni F; Peruzzi G; Sangiorgi M
    Boll Soc Ital Biol Sper; 1973 Feb; 49(3):79-84. PubMed ID: 4786553
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitory effects of central hypertensive activity of angiotensin I and II by 1-sar-8-ala-angiotensin II (saralasin acetate).
    Solomon TA; Buckley JP
    J Pharm Sci; 1974 Jul; 63(7):1109-13. PubMed ID: 4368826
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of the type of aneothesia on blood pressure, heart rate and pressor response to various pharmacodynamic stimulus in dogs].
    Sardi A; Scarselli V
    Boll Chim Farm; 1966 Aug; 105(8):584-90. PubMed ID: 4305823
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes of arterial blood pressure and respiration elicited by ventriculocerebral perfusion of some veratrum ester-alkaloids.
    Cuparencu B; Ticşa I; Csutak V; Safta L; Mocan R
    Acta Biol Med Ger; 1967; 19(3):435-46. PubMed ID: 5591161
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of the intraventricular administration of some hypotensive drugs on the arterial blood pressure and respiratory movements.
    Cuparencu B; Ticşa I; Csutak V; Safta L; Mocan R
    Acta Biol Med Ger; 1969; 23(6):799-812. PubMed ID: 5375482
    [No Abstract]   [Full Text] [Related]  

  • 12. Centrally mediated pressor response of angiotensin II in dogs.
    Singh KN; Varma S; Bharadwaj UR; Ghildyal SK
    Indian J Med Res; 1976 Jan; 64(1):138-43. PubMed ID: 1270094
    [No Abstract]   [Full Text] [Related]  

  • 13. Some aspects of the anatomy and physiology of the armadillo.
    Szabuniewicz M; McCrady JD
    Lab Anim Care; 1969 Dec; 19(6):843-8. PubMed ID: 4245154
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacology of xylite].
    Kryshen' PF; Rafes IuI; Krasovskaia AG; Genbacheva GB; Ardelian VN
    Farmakol Toksikol; 1971; 34(3):333-5. PubMed ID: 5568697
    [No Abstract]   [Full Text] [Related]  

  • 15. Some aspects of the pharmacology of valyl-beta-(pyrazolyl-3)-L-alanyl6-angiotensin II.
    Hageman WE; Hofmann K; Ertel RJ; Buckley JP
    J Pharmacol Exp Ther; 1969 Aug; 168(2):295-302. PubMed ID: 4308499
    [No Abstract]   [Full Text] [Related]  

  • 16. [On neurally facilitated circulatory effects of bradykinin and eledoisin].
    Felix W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):16-7. PubMed ID: 4231834
    [No Abstract]   [Full Text] [Related]  

  • 17. Depressor mechanism of synthetic ACTH (50022).
    Ueda M; Matsuda S; Kawakami M; Takeda H
    Jpn J Pharmacol; 1970 Dec; 20(4):585-98. PubMed ID: 4322119
    [No Abstract]   [Full Text] [Related]  

  • 18. The release of catecholamines from the adrenal medulla by peptides.
    Staszewska-Barczak J; Vane JR
    Br J Pharmacol Chemother; 1967 Aug; 30(3):655-67. PubMed ID: 4292940
    [No Abstract]   [Full Text] [Related]  

  • 19. The action of physalaemin on the systemic arterial blood pressure of some experimental animals.
    Bertaccini G; Cei JM; Erspamer V
    Br J Pharmacol Chemother; 1965 Oct; 25(2):380-91. PubMed ID: 4286324
    [No Abstract]   [Full Text] [Related]  

  • 20. [Toxicity problems with respect to angiographic contrast media].
    Zsebök ZB; Szlávy L
    Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):157-62. PubMed ID: 5425957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.